McInnes G, Yee S, Pershad Y, Altman R
Clin Pharmacol Ther. 2021; 110(3):637-648.
PMID: 34185318
PMC: 8376796.
DOI: 10.1002/cpt.2349.
Giangreco N, Elias J, Tatonetti N
Br J Clin Pharmacol. 2020; 88(4):1464-1470.
PMID: 33332641
PMC: 8209126.
DOI: 10.1111/bcp.14705.
Oni-Orisan A, Haldar T, Ranatunga D, Medina M, Schaefer C, Krauss R
NPJ Genom Med. 2020; 5:1.
PMID: 31969989
PMC: 6965183.
DOI: 10.1038/s41525-019-0109-4.
De T, Park C, Perera M
Annu Rev Pharmacol Toxicol. 2018; 59:577-603.
PMID: 30296897
PMC: 7482366.
DOI: 10.1146/annurev-pharmtox-010818-021154.
Coyle P
Mult Scler Int. 2017; 2017:6198530.
PMID: 28804651
PMC: 5540248.
DOI: 10.1155/2017/6198530.
Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.
Brozovich F, Nicholson C, Degen C, Gao Y, Aggarwal M, Morgan K
Pharmacol Rev. 2016; 68(2):476-532.
PMID: 27037223
PMC: 4819215.
DOI: 10.1124/pr.115.010652.
Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.
Yu H, Wang L, Lv L, Ma C, Du B, Lu T
Schizophr Bull. 2015; 42(3):814-23.
PMID: 26656879
PMC: 4838100.
DOI: 10.1093/schbul/sbv179.
Joint GWAS Analysis: Comparing similar GWAS at different genomic resolutions identifies novel pathway associations with six complex diseases.
McGeachie M, Clemmer G, Lasky-Su J, Dahlin A, Raby B, Weiss S
Genom Data. 2015; 2:202-211.
PMID: 25838990
PMC: 4378545.
DOI: 10.1016/j.gdata.2014.04.004.
Progress towards the integration of pharmacogenomics in practice.
Mooney S
Hum Genet. 2014; 134(5):459-65.
PMID: 25238897
PMC: 4362928.
DOI: 10.1007/s00439-014-1484-7.
Implementation and utilization of genetic testing in personalized medicine.
Abul-Husn N, Obeng A, Sanderson S, Gottesman O, Scott S
Pharmgenomics Pers Med. 2014; 7:227-40.
PMID: 25206309
PMC: 4157398.
DOI: 10.2147/PGPM.S48887.
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.
Greenbaum L, Goldwurm S, Zozulinsky P, Lifschytz T, Cohen O, Yahalom G
J Mol Neurosci. 2013; 51(2):380-8.
PMID: 23666822
DOI: 10.1007/s12031-013-0020-x.
Genotype-based ancestral background consistently predicts efficacy and side effects across treatments in CATIE and STAR*D.
Adkins D, Souza R, Aberg K, Clark S, McClay J, Sullivan P
PLoS One. 2013; 8(2):e55239.
PMID: 23405125
PMC: 3566192.
DOI: 10.1371/journal.pone.0055239.
Personalised medicine in paediatrics: individualising treatment in children with rare neurological diseases.
Scarpa M, Ceci A, Tomanin R, Mincarone P, Begley D
EPMA J. 2012; 2(2):231-9.
PMID: 23199151
PMC: 3405387.
DOI: 10.1007/s13167-011-0081-2.
Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling.
Hicks C, Kumar R, Pannuti A, Miele L
Breast Cancer (Auckl). 2012; 6:47-66.
PMID: 22399860
PMC: 3292850.
DOI: 10.4137/BCBCR.S8652.
Personalizing medicine with clinical pharmacogenetics.
Scott S
Genet Med. 2011; 13(12):987-95.
PMID: 22095251
PMC: 3290900.
DOI: 10.1097/GIM.0b013e318238b38c.
Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients.
Greenbaum L, Smith R, Lorberboym M, Alkelai A, Zozulinsky P, Lifschytz T
Psychopharmacology (Berl). 2011; 220(3):519-28.
PMID: 21947317
DOI: 10.1007/s00213-011-2499-6.
Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.
Russo R, Capasso M, Paolucci P, Iolascon A
Eur J Clin Pharmacol. 2010; 67 Suppl 1:17-27.
PMID: 21069522
DOI: 10.1007/s00228-010-0931-1.
An integrative method for scoring candidate genes from association studies: application to warfarin dosing.
Tatonetti N, Dudley J, Sagreiya H, Butte A, Altman R
BMC Bioinformatics. 2010; 11 Suppl 9:S9.
PMID: 21044367
PMC: 2967750.
DOI: 10.1186/1471-2105-11-S9-S9.
Genome-wide association studies in pharmacogenomics: successes and lessons.
Motsinger-Reif A, Jorgenson E, Relling M, Kroetz D, Weinshilboum R, Cox N
Pharmacogenet Genomics. 2010; 23(8):383-94.
PMID: 20639796
PMC: 3003940.
DOI: 10.1097/FPC.0b013e32833d7b45.
The public health utility of genome-wide association study results for smoking behavior.
Furberg H, Ostroff J, Lerman C, Sullivan P
Genome Med. 2010; 2(4):26.
PMID: 20423533
PMC: 2873804.
DOI: 10.1186/gm147.
